| scholarly article | Q13442814 |
| P50 | author | Nathan Salomonis | Q89864869 |
| Jaecheol Lee | Q98227025 | ||
| Sebastian Diecke | Q125904618 | ||
| P2093 | author name string | Joseph C Wu | |
| Michael P Snyder | |||
| Karim Sallam | |||
| Hogune Im | |||
| Joseph D Gold | |||
| Mingxia Gu | |||
| Mohamed Ameen | |||
| Meenakshi Venkatasubramanian | |||
| Jared M Churko | |||
| Gavin Wang | |||
| P2860 | cites work | Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures | Q39830573 |
| Generation of adult human induced pluripotent stem cells using nonviral minicircle DNA vectors | Q40813551 | ||
| Sodium butyrate promotes generation of human induced pluripotent stem cells through induction of the miR302/367 cluster | Q41809549 | ||
| Epigenetic repression of cardiac progenitor gene expression by Ezh2 is required for postnatal cardiac homeostasis. | Q41811528 | ||
| Costimulation-adhesion blockade is superior to cyclosporine A and prednisone immunosuppressive therapy for preventing rejection of differentiated human embryonic stem cells following transplantation | Q41852461 | ||
| Lab-specific gene expression signatures in pluripotent stem cells | Q44368751 | ||
| Model-based analysis of ChIP-Seq (MACS) | Q21183902 | ||
| Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles | Q24536351 | ||
| Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells | Q24620932 | ||
| Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks | Q24633890 | ||
| Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors | Q27860937 | ||
| Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. | Q28131663 | ||
| EnsMart: a generic system for fast and flexible access to biological data | Q28776411 | ||
| BEDTools: a flexible suite of utilities for comparing genomic features | Q29547332 | ||
| Circos: an information aesthetic for comparative genomics | Q29547653 | ||
| Epigenetic memory in induced pluripotent stem cells | Q29547892 | ||
| In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state | Q29614212 | ||
| Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds | Q29614344 | ||
| GREAT improves functional interpretation of cis-regulatory regions | Q29614846 | ||
| A more efficient method to generate integration-free human iPS cells | Q29615748 | ||
| Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome | Q29616636 | ||
| Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency | Q29616797 | ||
| Lentiviral vector design and imaging approaches to visualize the early stages of cellular reprogramming. | Q30499307 | ||
| Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy. | Q30539904 | ||
| The role of SIRT6 protein in aging and reprogramming of human induced pluripotent stem cells | Q30540850 | ||
| Identification of a specific reprogramming-associated epigenetic signature in human induced pluripotent stem cells | Q31092974 | ||
| AltAnalyze and DomainGraph: analyzing and visualizing exon expression data | Q33591086 | ||
| Genetic background drives transcriptional variation in human induced pluripotent stem cells | Q33716774 | ||
| A comparison of genetically matched cell lines reveals the equivalence of human iPSCs and ESCs | Q34045234 | ||
| Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells | Q34236195 | ||
| Reference Maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines | Q34714112 | ||
| MicroRNA cluster 302-367 enhances somatic cell reprogramming by accelerating a mesenchymal-to-epithelial transition | Q34948267 | ||
| ToppGene Suite for gene list enrichment analysis and candidate gene prioritization | Q34982758 | ||
| Implications of Glucose Transporter Protein Type 1 (GLUT1)-Haplodeficiency in Embryonic Stem Cells for Their Survival in Response to Hypoxic Stress | Q35843464 | ||
| Genetic Variability Overrides the Impact of Parental Cell Type and Determines iPSC Differentiation Potential | Q35896332 | ||
| Hypoxia Inhibits Myogenic Differentiation through p53 Protein-dependent Induction of Bhlhe40 Protein | Q36444267 | ||
| Whole-genome mutational burden analysis of three pluripotency induction methods. | Q36605066 | ||
| miR-429 regulates the transition between Hypoxia-Inducible Factor (HIF)1A and HIF3A expression in human endothelial cells | Q36661786 | ||
| Transcriptional and epigenetic dynamics during specification of human embryonic stem cells | Q37006585 | ||
| The regulatory role of c-MYC on HDAC2 and PcG expression in human multipotent stem cells | Q37295496 | ||
| A transcriptional roadmap to the induction of pluripotency in somatic cells | Q37718657 | ||
| Transcriptional upregulation of histone deacetylase 2 promotes Myc-induced oncogenic effects | Q38341800 | ||
| P433 | issue | 10 | |
| P921 | main subject | Human Induced Pluripotent Stem Cells | Q88981775 |
| P304 | page(s) | 826-837 | |
| P577 | publication date | 2017-10-03 | |
| P1476 | title | Transcriptomic and epigenomic differences in human induced pluripotent stem cells generated from six reprogramming methods | |
| P478 | volume | 1 |
| Q96692546 | High-throughput Preparation of DNA, RNA, and Protein from Cryopreserved Human iPSCs for Multi-omics Analysis |
| Q59360133 | Human Induced Pluripotent Stem Cell Production and Expansion from Blood using a Non-Integrating Viral Reprogramming Vector |
| Q94465343 | Metabolomics Analysis of Mesenchymal Stem Cells |
| Q91945569 | Microfluidic reprogramming to pluripotency of human somatic cells |
| Q89049041 | Progress, obstacles, and limitations in the use of stem cells in organ-on-a-chip models |
| Q58086434 | Systems-Wide Approaches in Induced Pluripotent Stem Cell Models |
| Q90253499 | The reprogramming method matters |
| Q58568612 | Use of human induced pluripotent stem cell-derived cardiomyocytes to assess drug cardiotoxicity |
| Q90139918 | cellHarmony: cell-level matching and holistic comparison of single-cell transcriptomes |
| Q64089132 | iPS-Cell Technology and the Problem of Genetic Instability—Can It Ever Be Safe for Clinical Use? |
Search more.